APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beta-Glucan Nutraceuticals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Beta-Glucan Nutraceuticals Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchBeta-Glucan Nutraceuticals Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Beta-Glucan Nutraceuticals Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Beta-Glucan Nutraceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beta-Glucan Nutraceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Beta-Glucan Nutraceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Beta-Glucan Nutraceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Beta-Glucan Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beta-Glucan Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beta-Glucan Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Beta-Glucan Nutraceuticals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Beta-Glucan Nutraceuticals market include Tate & Lyle, Super Beta Glucan, STR Biotech, Lesaffre Group, Kemin Industries, Garuda International, DSM and Ceapro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Beta-Glucan Nutraceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beta-Glucan Nutraceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beta-Glucan Nutraceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beta-Glucan Nutraceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Beta-Glucan Nutraceuticals Segment by Company

Tate & Lyle

Super Beta Glucan

STR Biotech

Lesaffre Group

Kemin Industries

Garuda International

DSM

Ceapro

Beta-Glucan Nutraceuticals Segment by Type

Mushroom Beta Glucan

Yeast Beta Glucan

Cereal Beta Glucan

Others

Beta-Glucan Nutraceuticals Segment by Application

Online Sale

Offline Sale

Beta-Glucan Nutraceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Beta-Glucan Nutraceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Beta-Glucan Nutraceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Beta-Glucan Nutraceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Beta-Glucan Nutraceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-Glucan Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beta-Glucan Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-Glucan Nutraceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Beta-Glucan Nutraceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Beta-Glucan Nutraceuticals industry.

Chapter 3: Detailed analysis of Beta-Glucan Nutraceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Beta-Glucan Nutraceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Beta-Glucan Nutraceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Beta-Glucan Nutraceuticals Industry Trends Table 2. Beta-Glucan Nutraceuticals Industry Drivers Table 3. Beta-Glucan Nutraceuticals Industry Opportunities and Challenges Table 4. Beta-Glucan Nutraceuticals Industry Restraints Table 5. Global Beta-Glucan Nutraceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Beta-Glucan Nutraceuticals Revenue Share by Company (2021-2026) Table 7. Global Beta-Glucan Nutraceuticals Sales Volume by Company (tons) & (2021-2026) Table 8. Global Beta-Glucan Nutraceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Beta-Glucan Nutraceuticals Average Price (US$/ton) of Company (2021-2026) Table 10. Global Beta-Glucan Nutraceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Beta-Glucan Nutraceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Beta-Glucan Nutraceuticals Company, Product Type & Application Table 13. Global Beta-Glucan Nutraceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Beta-Glucan Nutraceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mushroom Beta Glucan Table 18. Significant Companies of Yeast Beta Glucan Table 19. Significant Companies of Cereal Beta Glucan Table 20. Significant Companies of Others Table 21. Global Beta-Glucan Nutraceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Beta-Glucan Nutraceuticals Sales Volume by Type (2021-2026) & (tons) Table 23. Global Beta-Glucan Nutraceuticals Sales Volume by Type (2027-2032) & (tons) Table 24. Global Beta-Glucan Nutraceuticals Sales Volume Share by Type (2021-2026) Table 25. Global Beta-Glucan Nutraceuticals Sales Volume Share by Type (2027-2032) Table 26. Global Beta-Glucan Nutraceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Beta-Glucan Nutraceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Beta-Glucan Nutraceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Beta-Glucan Nutraceuticals Sales Value Share by Type (2021-2026) Table 30. Global Beta-Glucan Nutraceuticals Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Online Sale Table 32. Significant Companies of Offline Sale Table 33. Global Beta-Glucan Nutraceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 34. Global Beta-Glucan Nutraceuticals Sales Volume by Application (2021-2026) & (tons) Table 35. Global Beta-Glucan Nutraceuticals Sales Volume by Application (2027-2032) & (tons) Table 36. Global Beta-Glucan Nutraceuticals Sales Volume Share by Application (2021-2026) Table 37. Global Beta-Glucan Nutraceuticals Sales Volume Share by Application (2027-2032) Table 38. Global Beta-Glucan Nutraceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Beta-Glucan Nutraceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Beta-Glucan Nutraceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Beta-Glucan Nutraceuticals Sales Value Share by Application (2021-2026) Table 42. Global Beta-Glucan Nutraceuticals Sales Value Share by Application (2027-2032) Table 43. Global Beta-Glucan Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 44. Global Beta-Glucan Nutraceuticals Sales by Region (2021-2026) & (tons) Table 45. Global Beta-Glucan Nutraceuticals Sales Market Share by Region (2021-2026) Table 46. Global Beta-Glucan Nutraceuticals Sales by Region (2027-2032) & (tons) Table 47. Global Beta-Glucan Nutraceuticals Sales Market Share by Region (2027-2032) Table 48. Global Beta-Glucan Nutraceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Beta-Glucan Nutraceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Beta-Glucan Nutraceuticals Sales Value Share by Region (2021-2026) Table 51. Global Beta-Glucan Nutraceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Beta-Glucan Nutraceuticals Sales Value Share by Region (2027-2032) Table 53. Global Beta-Glucan Nutraceuticals Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global Beta-Glucan Nutraceuticals Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global Beta-Glucan Nutraceuticals Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 56. Global Beta-Glucan Nutraceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Beta-Glucan Nutraceuticals Sales by Country (2021-2026) & (tons) Table 58. Global Beta-Glucan Nutraceuticals Sales Market Share by Country (2021-2026) Table 59. Global Beta-Glucan Nutraceuticals Sales by Country (2027-2032) & (tons) Table 60. Global Beta-Glucan Nutraceuticals Sales Market Share by Country (2027-2032) Table 61. Global Beta-Glucan Nutraceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Beta-Glucan Nutraceuticals Sales Value Market Share by Country (2021-2026) Table 63. Global Beta-Glucan Nutraceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Beta-Glucan Nutraceuticals Sales Value Market Share by Country (2027-2032) Table 65. Tate & Lyle Company Information Table 66. Tate & Lyle Business Overview Table 67. Tate & Lyle Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Tate & Lyle Beta-Glucan Nutraceuticals Product Portfolio Table 69. Tate & Lyle Recent Development Table 70. Super Beta Glucan Company Information Table 71. Super Beta Glucan Business Overview Table 72. Super Beta Glucan Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Super Beta Glucan Beta-Glucan Nutraceuticals Product Portfolio Table 74. Super Beta Glucan Recent Development Table 75. STR Biotech Company Information Table 76. STR Biotech Business Overview Table 77. STR Biotech Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. STR Biotech Beta-Glucan Nutraceuticals Product Portfolio Table 79. STR Biotech Recent Development Table 80. Lesaffre Group Company Information Table 81. Lesaffre Group Business Overview Table 82. Lesaffre Group Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Lesaffre Group Beta-Glucan Nutraceuticals Product Portfolio Table 84. Lesaffre Group Recent Development Table 85. Kemin Industries Company Information Table 86. Kemin Industries Business Overview Table 87. Kemin Industries Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Kemin Industries Beta-Glucan Nutraceuticals Product Portfolio Table 89. Kemin Industries Recent Development Table 90. Garuda International Company Information Table 91. Garuda International Business Overview Table 92. Garuda International Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Garuda International Beta-Glucan Nutraceuticals Product Portfolio Table 94. Garuda International Recent Development Table 95. DSM Company Information Table 96. DSM Business Overview Table 97. DSM Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. DSM Beta-Glucan Nutraceuticals Product Portfolio Table 99. DSM Recent Development Table 100. Ceapro Company Information Table 101. Ceapro Business Overview Table 102. Ceapro Beta-Glucan Nutraceuticals Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Ceapro Beta-Glucan Nutraceuticals Product Portfolio Table 104. Ceapro Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Beta-Glucan Nutraceuticals Distributors List Table 108. Beta-Glucan Nutraceuticals Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Beta-Glucan Nutraceuticals Product Image Figure 2. Global Beta-Glucan Nutraceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Beta-Glucan Nutraceuticals Sales (2021-2032) & (tons) Figure 5. Global Beta-Glucan Nutraceuticals Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Beta-Glucan Nutraceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mushroom Beta Glucan Image Figure 10. Yeast Beta Glucan Image Figure 11. Cereal Beta Glucan Image Figure 12. Others Image Figure 13. Global Beta-Glucan Nutraceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Beta-Glucan Nutraceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Beta-Glucan Nutraceuticals Sales Volume Share by Type (2021-2032) Figure 16. Global Beta-Glucan Nutraceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Beta-Glucan Nutraceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Beta-Glucan Nutraceuticals Sales Value Share by Type (2021-2032) Figure 19. Online Sale Image Figure 20. Offline Sale Image Figure 21. Global Beta-Glucan Nutraceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 22. Global Beta-Glucan Nutraceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Beta-Glucan Nutraceuticals Sales Volume Share by Application (2021-2032) Figure 24. Global Beta-Glucan Nutraceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Beta-Glucan Nutraceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Beta-Glucan Nutraceuticals Sales Value Share by Application (2021-2032) Figure 27. Global Beta-Glucan Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 28. Global Beta-Glucan Nutraceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Beta-Glucan Nutraceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Beta-Glucan Nutraceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 32. North America Beta-Glucan Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Beta-Glucan Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Beta-Glucan Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 38. South America Beta-Glucan Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Beta-Glucan Nutraceuticals Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Beta-Glucan Nutraceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Beta-Glucan Nutraceuticals Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Beta-Glucan Nutraceuticals Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Mushroom Beta Glucan
  • Yeast Beta Glucan
  • Cereal Beta Glucan
  • Others
Applications
  • Online Sale
  • Offline Sale
Companies covered
  • Tate & Lyle
  • Super Beta Glucan
  • STR Biotech
  • Lesaffre Group
  • Kemin Industries
  • Garuda International
  • DSM
  • Ceapro

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Beta-Glucan Nutraceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Beta-Glucan Nutraceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Beta-Glucan Nutraceuticals Market Dynamics
  1. 2.1 Beta-Glucan Nutraceuticals Industry Trends
  2. 2.2 Beta-Glucan Nutraceuticals Industry Drivers
  3. 2.3 Beta-Glucan Nutraceuticals Industry Opportunities and Challenges
  4. 2.4 Beta-Glucan Nutraceuticals Industry Restraints
3 Beta-Glucan Nutraceuticals Market by Company
  1. 3.1 Global Beta-Glucan Nutraceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Beta-Glucan Nutraceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Beta-Glucan Nutraceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Beta-Glucan Nutraceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Beta-Glucan Nutraceuticals Company Ranking (2024-2026)
  6. 3.6 Global Beta-Glucan Nutraceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Beta-Glucan Nutraceuticals Company Product Type and Application
  8. 3.8 Global Beta-Glucan Nutraceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Beta-Glucan Nutraceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Beta-Glucan Nutraceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Beta-Glucan Nutraceuticals Market by Type
  1. 4.1 Beta-Glucan Nutraceuticals Type Introduction
  2. 4.1.1 Mushroom Beta Glucan
  3. 4.1.2 Yeast Beta Glucan
  4. 4.1.3 Cereal Beta Glucan
  5. 4.1.4 Others
  6. 4.2 Global Beta-Glucan Nutraceuticals Sales Volume by Type
  7. 4.2.1 Global Beta-Glucan Nutraceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Beta-Glucan Nutraceuticals Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Beta-Glucan Nutraceuticals Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Beta-Glucan Nutraceuticals Sales Value by Type
  11. 4.3.1 Global Beta-Glucan Nutraceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Beta-Glucan Nutraceuticals Sales Value by Type (2021-2032)
  13. 4.3.3 Global Beta-Glucan Nutraceuticals Sales Value Share by Type (2021-2032)
5 Beta-Glucan Nutraceuticals Market by Application
  1. 5.1 Beta-Glucan Nutraceuticals Application Introduction
  2. 5.1.1 Online Sale
  3. 5.1.2 Offline Sale
  4. 5.2 Global Beta-Glucan Nutraceuticals Sales Volume by Application
  5. 5.2.1 Global Beta-Glucan Nutraceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Beta-Glucan Nutraceuticals Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Beta-Glucan Nutraceuticals Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Beta-Glucan Nutraceuticals Sales Value by Application
  9. 5.3.1 Global Beta-Glucan Nutraceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Beta-Glucan Nutraceuticals Sales Value by Application (2021-2032)
  11. 5.3.3 Global Beta-Glucan Nutraceuticals Sales Value Share by Application (2021-2032)
6 Beta-Glucan Nutraceuticals Regional Sales and Value Analysis
  1. 6.1 Global Beta-Glucan Nutraceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Beta-Glucan Nutraceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Beta-Glucan Nutraceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Beta-Glucan Nutraceuticals Sales by Region (2027-2032)
  5. 6.3 Global Beta-Glucan Nutraceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Beta-Glucan Nutraceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Beta-Glucan Nutraceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Beta-Glucan Nutraceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Beta-Glucan Nutraceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Beta-Glucan Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Beta-Glucan Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Beta-Glucan Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Beta-Glucan Nutraceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Beta-Glucan Nutraceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Beta-Glucan Nutraceuticals Sales Value Share by Country, 2025 VS 2032
7 Beta-Glucan Nutraceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Beta-Glucan Nutraceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Beta-Glucan Nutraceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Beta-Glucan Nutraceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Beta-Glucan Nutraceuticals Sales by Country (2027-2032)
  6. 7.4 Global Beta-Glucan Nutraceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Beta-Glucan Nutraceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Beta-Glucan Nutraceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Beta-Glucan Nutraceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Beta-Glucan Nutraceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Beta-Glucan Nutraceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tate & Lyle
  2. 8.1.1 Tate & Lyle Company Information
  3. 8.1.2 Tate & Lyle Business Overview
  4. 8.1.3 Tate & Lyle Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tate & Lyle Beta-Glucan Nutraceuticals Product Portfolio
  6. 8.1.5 Tate & Lyle Recent Developments
  7. 8.2 Super Beta Glucan
  8. 8.2.1 Super Beta Glucan Company Information
  9. 8.2.2 Super Beta Glucan Business Overview
  10. 8.2.3 Super Beta Glucan Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Super Beta Glucan Beta-Glucan Nutraceuticals Product Portfolio
  12. 8.2.5 Super Beta Glucan Recent Developments
  13. 8.3 STR Biotech
  14. 8.3.1 STR Biotech Company Information
  15. 8.3.2 STR Biotech Business Overview
  16. 8.3.3 STR Biotech Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 STR Biotech Beta-Glucan Nutraceuticals Product Portfolio
  18. 8.3.5 STR Biotech Recent Developments
  19. 8.4 Lesaffre Group
  20. 8.4.1 Lesaffre Group Company Information
  21. 8.4.2 Lesaffre Group Business Overview
  22. 8.4.3 Lesaffre Group Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lesaffre Group Beta-Glucan Nutraceuticals Product Portfolio
  24. 8.4.5 Lesaffre Group Recent Developments
  25. 8.5 Kemin Industries
  26. 8.5.1 Kemin Industries Company Information
  27. 8.5.2 Kemin Industries Business Overview
  28. 8.5.3 Kemin Industries Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kemin Industries Beta-Glucan Nutraceuticals Product Portfolio
  30. 8.5.5 Kemin Industries Recent Developments
  31. 8.6 Garuda International
  32. 8.6.1 Garuda International Company Information
  33. 8.6.2 Garuda International Business Overview
  34. 8.6.3 Garuda International Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Garuda International Beta-Glucan Nutraceuticals Product Portfolio
  36. 8.6.5 Garuda International Recent Developments
  37. 8.7 DSM
  38. 8.7.1 DSM Company Information
  39. 8.7.2 DSM Business Overview
  40. 8.7.3 DSM Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DSM Beta-Glucan Nutraceuticals Product Portfolio
  42. 8.7.5 DSM Recent Developments
  43. 8.8 Ceapro
  44. 8.8.1 Ceapro Company Information
  45. 8.8.2 Ceapro Business Overview
  46. 8.8.3 Ceapro Beta-Glucan Nutraceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceapro Beta-Glucan Nutraceuticals Product Portfolio
  48. 8.8.5 Ceapro Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Beta-Glucan Nutraceuticals Value Chain Analysis
  2. 9.1.1 Beta-Glucan Nutraceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Beta-Glucan Nutraceuticals Sales Mode & Process
  6. 9.2 Beta-Glucan Nutraceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Beta-Glucan Nutraceuticals Distributors
  9. 9.2.3 Beta-Glucan Nutraceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst